"At Clarient, we combine world class pathology with innovation and our goal is to make a difference to physicians and their patients," said Kenneth Bloom, MD, chief medical officer, Clarient Diagnostic Services. "Our work with Definiens will enable us to offer high quality, robust readouts with fast turnaround time. This means physicians will have better patient insights for diagnosis."
"We are really pleased to work with Clarient on creating these validated applications for their routine clinical work. Running thousands of patient slides through our algorithms and seeing the computer-aided diagnosis in action is really gratifying," said Thomas Heydler, chief executive officer of Definiens.